eCite Digital Repository
How should the patient with multiple endocrine neoplasia type 1 (MEN 1) be followed?
Citation
Burgess, John, How should the patient with multiple endocrine neoplasia type 1 (MEN 1) be followed?, Clinical Endocrinology, 72, (1) pp. 13-16. ISSN 0300-0664 (2010) [Refereed Article]
DOI: doi:10.1111/j.1365-2265.2009.03662.x
Abstract
Multiple endocrine neoplasia type 1 (MEN 1) is a complex multi-system disease manifesting a diverse range of primary and secondary metabolic and neoplastic disorders. It is possible to improve patient prognosis by early disease detection and treatment. Regular biochemical and radiological screening for parathyroid, gastro-enteropancreatic, pituitary, intrathorasic and adrenal lesions forms the basis of surveillance. The likelihood of adverse sequelea such as renal and bone disease resulting from hyperparathyroidism, severe peptic ulceration and gastric carcinoidosis secondary to hypergastrinaemia can be ameliorated by early detection and management
Item Details
| Item Type: | Refereed Article |
|---|---|
| Research Division: | Biomedical and Clinical Sciences |
| Research Group: | Clinical sciences |
| Research Field: | Endocrinology |
| Objective Division: | Health |
| Objective Group: | Clinical health |
| Objective Field: | Clinical health not elsewhere classified |
| UTAS Author: | Burgess, John (Professor John Burgess) |
| ID Code: | 96141 |
| Year Published: | 2010 |
| Web of Science® Times Cited: | 15 |
| Deposited By: | Medicine |
| Deposited On: | 2014-10-21 |
| Last Modified: | 2014-10-21 |
| Downloads: | 0 |
Repository Staff Only: item control page